GlassScriptPhysician profile
Luis D Acosta
NPI 1235140997
$8,617.57
in general payments reported to CMS, 2019-2025
41 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $1,093 · 2021: $1,792 · 2022: $1,856 · 2023: $502 · 2024: $554 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,114 · Education: $17.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,113.65 |
| Education | $17.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $840.21 | 2019-2025 | Briviact, Nayzilam, Fintepla |
| Teva Pharmaceuticals USA, INC. | $756.52 | 2019-2023 | Austedo, Austedo Xr |
| Emd Serono, INC. | $748.23 | 2019-2024 | |
| Genentech USA, INC. | $643.47 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Alexion Pharmaceuticals, INC. | $624.94 | 2019-2025 | Ultomiris |
| Neurocrine Biosciences, INC. | $598.55 | 2019-2023 | Ingrezza, Ongentys |
| Biogen, INC. | $494.68 | 2019-2025 | Vumerity |
| Argenx US, INC. | $491.78 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Amgen INC. | $459.59 | 2019-2025 | Uplizna |
| Medtronic USA, INC. | $333.43 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $302.46 | 2019-2024 | Rytary |
| Abbvie INC. | $301.54 | 2019-2025 | Ubrelvy |
| Medtronic, INC. | $296.34 | 2021-2025 | Minimed 780g |
| Lilly USA, LLC | $196.27 | 2019-2025 | Kisunla |
| Lundbeck LLC | $192.28 | 2020-2025 | Vyepti |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Acosta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.